Your browser doesn't support javascript.
loading
Cerebrospinal fluid levels of sphingolipids associate with disease severity in first episode psychosis patients.
Checa, Antonio; Malmqvist, Anna; Flyckt, Lena; Schwieler, Lilly; Samuelsson, Martin; Skogh, Elisabeth; Cervenka, Simon; Dahl, Marja-Liisa; Piehl, Fredrik; Erhardt, Sophie; Wheelock, Craig E.
Afiliação
  • Checa A; Division of Physiological Chemistry II, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-171 77 Stockholm, Sweden.
  • Malmqvist A; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Flyckt L; Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm, Sweden.
  • Schwieler L; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Samuelsson M; Center for Social and Affective Neuroscience, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden; Department of Psychiatry, Local Health Care Services in Central Östergötland, Region Östergötland, Linköping, Sweden.
  • Skogh E; Center for Social and Affective Neuroscience, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden; Department of Psychiatry, Local Health Care Services in Central Östergötland, Region Östergötland, Linköping, Sweden.
  • Cervenka S; Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm, Sweden.
  • Dahl ML; Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Piehl F; Department of Clinical Neurosciences, Section of Neurology, Karolinska Institutet, Stockholm, Sweden.
  • Erhardt S; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Wheelock CE; Division of Physiological Chemistry II, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-171 77 Stockholm, Sweden. Electronic address: craig.wheelock@ki.se.
Schizophr Res ; 199: 438-441, 2018 09.
Article em En | MEDLINE | ID: mdl-29627172
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esfingolipídeos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Schizophr Res Assunto da revista: PSIQUIATRIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esfingolipídeos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Schizophr Res Assunto da revista: PSIQUIATRIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suécia